Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India

Gene and cell therapies for a variety of life-limiting illnesses are under investigation, and a small number of commercial products have successfully obtained regulatory approval. The cost of treatment is high, and clinical studies evaluating safety and efficacy are performed predominately in high-i...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornetta, Kenneth, Bonamino, Martín, Mahlangu, Johnny, Mingozzi, Federico, Rangarajan, Savita, Rao, Jayandharan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171243/
https://www.ncbi.nlm.nih.gov/pubmed/35390542
http://dx.doi.org/10.1016/j.ymthe.2022.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171243/
https://www.ncbi.nlm.nih.gov/pubmed/35390542
http://dx.doi.org/10.1016/j.ymthe.2022.04.002

Ejemplares similares